Company intelligence / Profile preview

SK-II

Kobe, Hyogo, Japan

Ownership: Private
Development stage: Other

Overview

SK-II is a global prestige skincare brand owned by Procter & Gamble, specializing in high-performance dermatological products. The brand is built around its proprietary ingredient, Pitera, a yeast-derived ferment filtrate discovered in a Japanese sake brewery. Pitera contains over 50 micro-nutrients that help maintain skin health and address signs of aging, such as fine lines and loss of elasticity. SK-II utilizes advanced biotechnological fermentation and skin-imaging technologies to develop its product line. Its flagship Facial Treatment Essence remains a cornerstone of the luxury skincare market worldwide.

Therapeutic areas: Dermatology
Modalities: BiologicSmall moleculeTopical formulation
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on SK-II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SK-II.

Explore the full profile